Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-α) in the Chinese patients with major depressive disorder: A prospective longitudinal study

Psychoneuroendocrinology - Tập 38 - Trang 107-114 - 2013
Zezhi Li1, Dake Qi2, Jun Chen1, Chen Zhang1, Zhenghui Yi1, Chengmei Yuan1, Zuowei Wang1,3, Wu Hong1, Shunying Yu4, Donghong Cui4, Yiru Fang1
1Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2Department of Internal Medicine, Yale University School of Medicine, New Haven, CT USA
3Department of Psychiatry, Hongkou District Mental Health Center, Shanghai, China
4Department of Genetics, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Tài liệu tham khảo

Anisman, 2008, Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders, Prog. Neurobiol., 85, 1, 10.1016/j.pneurobio.2008.01.004

Boomsma, 2008, Genome-wide association of major depression: description of samples for the GAIN Major Depressive Disorder Study: NTR and NESDA biobank projects, Eur. J. Hum. Genet., 16, 335, 10.1038/sj.ejhg.5201979

Borges, 2011, Suicidality, ethnicity and immigration in the USA, Psychol. Med., 26, 1

Bosker, 2011, Poor replication of candidate genes for major depressive disorder using genome-wide association data, Mol. Psychiatry, 16, 516, 10.1038/mp.2010.38

Ching, 2007, Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration, J. Neurosci., 27, 10476, 10.1523/JNEUROSCI.3357-07.2007

Dantzer, 2001, Cytokine-induced sickness behavior: where do we stand?, Brain Behav. Immun., 15, 7, 10.1006/brbi.2000.0613

Dantzer, 2008, From inflammation to sickness and depression: when the immune system subjugates the brain, Nat. Rev. Neurosci., 9, 46, 10.1038/nrn2297

Eller, 2008, Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder, Prog. Neuropsychopharmacol. Biol. Psychiatry, 32, 445, 10.1016/j.pnpbp.2007.09.015

Ertenli, 2012, Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level, Rheumatol. Int., 32, 323, 10.1007/s00296-010-1616-x

Fang, 2010, Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression. A double-blind, randomized pilot study in a Chinese population, J. Clin. Psychopharmacol., 30, 357, 10.1097/JCP.0b013e3181e7784f

Felger, 2007, Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression, Biol. Psychiatry, 62, 1324, 10.1016/j.biopsych.2007.05.026

Fornaro, 2011, Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60mg/day: a preliminary observation, Neuropsychiatr. Dis. Treat., 7, 51, 10.2147/NDT.S16382

Gabbay, 2009, A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression, J. Child Adolesc. Psychopharmacol., 19, 423, 10.1089/cap.2008.0140

Hannestad, 2011, The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis, Neuropsychopharmacology, 36, 2452, 10.1038/npp.2011.132

Himmerich, 2006, Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis, Biol. Psychiatry, 60, 882, 10.1016/j.biopsych.2006.03.075

Himmerich, 2008, Depression, comorbidities and the TNF-alpha system, Eur. Psychiatry, 23, 421, 10.1016/j.eurpsy.2008.03.013

Huang, 2011, LPS-stimulated tumor necrosis factor-alpha and interleukin-6 mRNA and cytokine responses following acute psychological stress, Psychoneuroendocrinology, 36, 1553, 10.1016/j.psyneuen.2011.04.009

Jacobson, 2007, Feeling strained? Influence of genetic background on depression-related behavior in mice: a review, Behav. Genet., 37, 171, 10.1007/s10519-006-9106-3

Janelidze, 2011, Cytokine levels in the blood may distinguish suicide attempters from depressed patients, Brain Behav. Immun., 25, 335, 10.1016/j.bbi.2010.10.010

Kaster, 2012, Depressive-like behavior induced by tumor necrosis factor-alpha in mice, Neuropharmacology, 62, 419, 10.1016/j.neuropharm.2011.08.018

Kelley, 2003, Cytokine-induced sickness behavior, Brain Behav. Immun., 17, S112, 10.1016/S0889-1591(02)00077-6

Kempermann, 2003, Depressed new neurons-adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression, Biol. Psychiatry, 54, 499, 10.1016/S0006-3223(03)00319-6

Kessler, 2003, The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R), JAMA, 289, 3095, 10.1001/jama.289.23.3095

Kraus, 2002, Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine, Pharmacopsychiatry, 35, 220, 10.1055/s-2002-36390

Larney, 2012, A cross-sectional survey of prevalence and correlates of suicidal ideation and suicide attempts among prisoners in New South Wales, Australia, BMC Public Health, 12, 14, 10.1186/1471-2458-12-14

Lin, 2001, Biological differences in depression and anxiety across races and ethnic groups, J. Clin. Psychiatry, 62, S13

Liu, 2011, Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression, J. Affect. Disord.

Miller, 2009, Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression, Biol. Psychiatry, 65, 732, 10.1016/j.biopsych.2008.11.029

Narita, 2006, Plasma levels of adiponectin and tumor necrosis factor-alpha in patients with remitted major depression receiving long-term maintenance antidepressant therapy, Prog. Neuropsychopharmacol. Biol. Psychiatry, 30, 1159, 10.1016/j.pnpbp.2006.03.030

O’Connor, 2009, Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin, J. Neurosci., 29, 4200, 10.1523/JNEUROSCI.5032-08.2009

Pavon, 2006, Th2 cytokine response in major depressive disorder patients before treatment, J. Neuroimmunol., 172, 156, 10.1016/j.jneuroim.2005.08.014

Piletz, 2009, Pro-inflammatory biomakers in depression: treatment with venlafaxine, World J. Biol. Psychiatry, 10, 313, 10.3109/15622970802573246

Simon, 2008, A detailed examination of cytokine abnormalities in major depressive disorder, Eur. Neuropsychopharmacol., 18, 230, 10.1016/j.euroneuro.2007.06.004

Steiner, 2008, Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide, J. Psychiatr. Res., 42, 151, 10.1016/j.jpsychires.2006.10.013

Tuglu, 2003, Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder, Psychopharmacology (Berl), 170, 429, 10.1007/s00213-003-1566-z

Tyring, 2006, Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial, Lancet, 367, 29, 10.1016/S0140-6736(05)67763-X

Vollmar, 2009, The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines, Int. J. Neuropsychopharmacol., 12, 525, 10.1017/S1461145708009425

Waldman, 2009, Ethnic differences in the treatment of depression in patients with ischemic heart disease, Am. Heart J., 157, 77, 10.1016/j.ahj.2008.08.013

Yoshimura, 2009, Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression, Prog. Neuropsychopharmacol. Biol. Psychiatry, 33, 722, 10.1016/j.pnpbp.2009.03.020

Thông tin
Thông tin xuất bản

Psychoneuroendocrinology

Tập 38

107-114

Thông tin tác giả